Abcam founder speaks out against growing exodus of British life science companies
Jonathan Milner, a leading UK breast cancer specialist who founded biotech group Abcam in 1998, is aiming to thwart a US takeover bid.
Stay updated with breaking news from Jonathan Milner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jonathan Milner, a leading UK breast cancer specialist who founded biotech group Abcam in 1998, is aiming to thwart a US takeover bid.
Dr Jonathan Milner speaks to Thomas Warner from Proactive London about why he believes shareholders should vote against Life Science Company Abcam's...
Abcam plc , a global leader in the supply of life science research tools, today filed and mailed a scheme circular in connection with the acquisition of Abcam by Danaher Corporation , announced on...
FTI Consulting represents British life sciences company Abcam as it defends its $5.7B takeover by DC-based Danaher.
Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its Series A financing.